# Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?

> **NCT06732843** · — · RECRUITING · sponsor: **ART Fertility Clinics LLC** · enrollment: 10 (estimated)

## Conditions studied

- OVARIAN STIMULATION
- Telomere Length
- Telomere Length, Mean Leukocyte

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06732843
- **Lead sponsor:** ART Fertility Clinics LLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-23
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06732843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06732843, "Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06732843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*